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Abstract
Neurons can activate pathways that destroy the whole cell via apoptosis or selectively degenerate 
only the axon (pruning). Both apoptosis and axon degeneration require Bax and caspases. Here we 
demonstrate that despite this overlap, the pathways mediating axon degeneration during apoptosis 
versus axon pruning are distinct. While caspase-6 is activated in axons following nerve growth 
factor (NGF) deprivation, microfluidic chamber experiments reveal that caspase-6 deficiency only 
protects axons during axon-specific but not whole-cell (apoptotic) NGF deprivation. Strikingly, 
axon-selective degeneration requires the apoptotic proteins Caspase-9 and Caspase-3 but, in 
contrast to apoptosis, not Apaf-1. Additionally, cell bodies of degenerating axons are protected 
from caspase activation by protea some activity and XIAP. Also, mature neurons restrict apoptosis 
but remain permissive for axon degeneration, further demonstrating the independent regulation of 
these two pathways. These results reveal insight into how neurons allow for precise control over 
apoptosis and axon-selective degeneration pathways, thereby permitting long-term plasticity 
without risking neurodegeneration.
Neurons execute one of two critical self-destruct programs to properly shape the developing 
nervous system: apoptosis, which destroys the entire neuron, and axon degeneration, which 
removes unnecessary axon branches to refine neuronal connections1,2. While extensive 
neuronal apoptosis occurs during development3, the apoptotic pathway becomes highly 
restricted once neurons are integrated in the nervous system, enabling neurons to survive for 
the lifetime of the organism4-7. In contrast, the selective pruning of axons is critical not only 
for establishing specific neuronal circuitry during development but also for permitting 
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plasticity in the adult nervous system8-10. Although axons are destroyed during both 
apoptosis and axon-specific degeneration, whether exactly the same pathway mediates 
axonal destruction in these two contexts has not been specifically examined.
The key mediators of the apoptosis pathway are caspases, a family of cysteine proteases that 
cleave specific cellular substrates to cause rapid cell death11. Apoptotic signaling cascades 
converge on and activate Bax, a proapoptotic member of the Bcl-2 family, resulting in the 
release of cytochrome c(cytc)from the mitochondria. Released cytc binds to Apaf-1 
(Apoptotic protease activating factor 1), which recruits procaspase-9 to form the 
apoptosome complex. Auto activation of caspase-9 (Casp9) leads to the cleavage and 
activation of caspase-3 (Casp3), resulting in cell death. Caspase activation in neurons is 
strictly regulated by XIAP (X-linked inhibitor of apoptosis protein), which binds to and 
inhibits cleaved Casp9 and Casp3. Thus, inactivation of XIAP is necessary for caspase-
mediated apoptosis in neurons12.
Any overlap between neuronal apoptosis and axon-specific degeneration was initially 
dismissed due to the lack of active Casp3 detection in degenerating axons and the inability 
of Casp3-specific inhibition to protect axons13-15. Interestingly, however, recent studies 
point to significant overlap between these two pathways. For example, the Bcl-2 family 
proteins have been shown to modulate axon degeneration as deficiency of Bax or over 
expression of anti-apoptotic protein Bcl-XL both protect axons following axon-specific 
nerve growth factor (NGF) deprivation13,16,17. Furthermore, several caspases - specifically 
Casp9, Casp3, and caspase-6 (Casp6) -have now all been implicated in axon 
degeneration13,17-23.These results raise several interesting points. If the effectors of 
apoptosis and axon degeneration are identical, how do neurons activate axon-selective 
degeneration without triggering apoptosis? Alternatively, are there key differences that 
remain unidentified that allow neurons to precisely activate one but not the other pathway?
In this study, we examine the molecular intersection between axon degeneration and 
apoptosis. We report that the pathways mediating axon degeneration in the context of 
apoptosis versus localized, axon-specific degeneration are distinct. We also find that 
activities of the proteasome and XIAP are important for restricting caspase activation to the 
axons during axon-selective degeneration. Importantly, we show that mature neurons, which 
restrict apoptosis, are still capable of undergoing axon-specific degeneration, further 
supporting our conclusion that neuronal apoptosis and axon degeneration are mediated by 
different mechanisms. The distinct regulation of these two pathways is essential for 
maintaining life-long neuronal plasticity without risking neurodegeneration.
Results
Axon-selective pruning requires Casp6
As Casp6 has emerged as an important mediator of axon degeneration, we examined 
whether Casp6 is activated in multiple models of axon degeneration. We subjected whole 
cultures of primary mouse sympathetic neurons to various insults in vitro, including NGF 
deprivation, DNA damage with etoposide, ER stress with tunicamycin, and microtubule 
destabilization with vinblastine. Consistent with recent reports17, despite the ability of all 
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treatments to induce extensive axon degeneration (Fig. 1a), we detected robust axonal Casp6 
staining selectively following NGF deprivation but not other insults (Fig. 1b). NGF 
deprivation is known to induce apoptosis in neurons resulting in both soma and axon 
degeneration. To test whether Casp6 was required for axon degeneration in this model, we 
isolated neurons from wild type and Casp6-deficient mice and deprived them of NGF. 
Surprisingly, Casp6 deficiency did not prevent axon degeneration in NGF-deprived neurons; 
Casp6-deficient neurons underwent apoptosis and exhibited soma and axon degeneration 
just as seen with wild type neurons (Fig. 2a).
These results were unexpected because recent studies have shown that Casp6 is required for 
axon degeneration13,20. However, in these studies, neurons were cultured in 
compartmentalized chambers and NGF was withdrawn from only the axons. Thus, we 
examined whether neurons activate a Casp6-dependent or -independent pathway to 
degenerate axons based on the spatial localization of NGF deprivation signal. We generated 
microfluidic chambers that permit the physical separation and fluidic isolation of soma and 
distal axons24 microfluidic chambers allow local NGF withdrawal from distal axons in the 
axon compartment while maintaining NGF on the cell bodies and proximal axons in the 
soma compartment (Fig. 2b). This axon-specific NGF withdrawal, termed local deprivation, 
results in axon-specific degeneration in wild type neurons within 24-48 hours. Alternatively, 
we can also withdraw NGF from both compartments, termed global deprivation, to induce 
whole-cell degeneration via apoptosis.
Using microfluidic chambers to clearly distinguish axon degeneration caused by apoptosis 
versus that during axon-specific NGF deprivation, we subjected wild type and Casp6-
deficient neurons to global and local deprivation. Our results show that while Casp6 
deficiency is indeed able to block axon degeneration with local deprivation, it is incapable of 
doing so with global deprivation (Figs. 2c,d; Supplemental Fig. S1). These results indicate 
that the Casp6-mediated pathway of axon degeneration induced during local deprivation is 
distinct from the pathway utilized by dying neurons to degenerate their axons. Thus, neurons 
appear to have Casp6-dependent and Casp6-independent pathways to degenerate their 
axons, and the specific location of NGF withdrawal (axon versus whole cell) determines 
which pathway becomes activated.
Apaf-1-independent axon pruning requires Casp9 and Casp3
The requirement of Casp6 in the axon-selective degeneration pathway but not apoptosis 
indicates that these two pathways are distinct. However, deficiency of Bax protects against 
both neuronal apoptosis and local deprivation-induced axon degeneration13,16. Thus, the 
apoptotic pathway intersects with the axon degeneration pathway. Since death receptor 6 
(DR6) has been implicated in Casp6 activation in axon degeneration13, we first examined 
whether the death receptor apoptotic pathway, also known as the extrinsic pathway, was 
important for axon degeneration. In the extrinsic pathway, activation of caspase-8can either 
directly activate Casp3 or cleave Bid, a proapoptotic member of the Bcl-2 family of 
proteins, which then activates Bax25. However, neither Bid-deficiency nor caspase-8-
specific inhibition blocked axon degeneration during local deprivation (Supplemental Figs. 
S2a,b).
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We next tested whether components of the mitochondrial apoptotic pathway are critical for 
axon-selective degeneration using mice deficient in the key components of this pathway. As 
anticipated, Bax-deficient axons were protected during local deprivation and lacked Casp6 
activation (Figs. 3a-c). Both Casp9 and Casp3 were also required for axon degeneration 
following local deprivation as axons deficient for these respective caspases were protected 
(Figs. 3a-c). Indeed, we detected active Casp3 in locally deprived wild type axons, 
indicating that Casp3 is activated during axon-selective degeneration (Fig.3b). Interestingly, 
we also examined the status of cleaved Casp6 in these knockout neurons that were locally 
deprived of NGF. While noactive Casp6 staining was detected in locally-deprived Bax- or 
Casp9-deficient neurons, we observed positive staining in the Casp3-deficient neurons, 
albeit to a reduced extent than seen in wild type neurons (Fig. 3a). These results suggest that 
Casp6 cleavage occurs downstream of Bax and Casp9. Importantly, Casp3 appears to be 
required for full Casp6 activation in locally deprived axons.
Next, we examined the importance of the key apoptotic protein Apaf-1 in axon 
degeneration. Similar to neurons deficient for Bax, Casp9, and Casp3, neurons deficient for 
Apaf-1 are protected from apoptosis induced by NGF deprivation26. Strikingly, Apaf-1 
deficiency did not block axon-selective degeneration following local deprivation (Fig. 3, 
Supplemental Fig. S2c). Similar to wild type neurons, robust Casp6 activation was also seen 
in Apaf-1-deficient neurons (Fig. 3a). These results indicate that while axon-selective 
degeneration is Casp9- and Casp3-dependent, it is Apaf-1-independent.
As active Bax is known to trigger mitochondrial cytc release during apoptosis, we also 
examined the status of cytc in deprived axons. Control axons in the presence of NGF 
maintained cytc in the mitochondria and global deprivation triggered its release (as indicated 
by the loss of cytc staining). Our results show that local deprivation also induced the release 
of cytc from mitochondria in the axon compartment (Fig. 4).
Together, these results show that axon degeneration during apoptosis versus axon-selective 
pruning have some overlap but also key differences. While both pathways require Bax, 
Casp9, and Casp3, they diverge at the requirements of Casp6 (required only for axon-
selective pruning) and Apaf-1 (required only for axon degeneration during apoptosis).
XIAP and the proteasome protect the soma during axon pruning
The unexpected involvement of proapoptoticcaspases in axon degeneration raises a key 
question of how neurons can limit caspase activity to axons without increasing the risk of 
apoptosis at the soma. While some have reported proteasome inhibition to inhibit axon 
degeneration27,28 others have reported the opposite effect29,30 Recently, Casp6 activity was 
reported to be enhanced by proteasome inhibition31,32. Indeed, we detected Casp6 activation 
and axon degeneration at an earlier time point when proteasome activity was inhibited with 
Bortezomib (Fig. 5a; Supplemental Fig. S3a) or MG132 (data not shown). Equally striking, 
proteasome inhibition made the cell bodies of locally deprived axons more permissive for 
caspase activation; significantly more Casp3- and Casp9-positive cell bodies were observed 
in locally deprived, proteasome-inhibited chambers than those that had been locally 
deprived without proteasome inhibitor (Figs. 5b,c). Proteasome inhibition alone did not 
induce Casp3 activation in NGF-maintained neurons (Fig. 5a). Also, the increased axon 
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degeneration seen with proteasome inhibition after local deprivation was Casp3-dependent, 
indicating that this degeneration was not due to non-specific toxicity of proteasome 
inhibition (Fig. 5d).
Another factor that can restrict caspase activation during axon-specific degeneration is 
XIAP, which is a potent endogenous inhibitor of caspases in neurons12. Due to the 
requirement of two critical targets of XIAP (Casp9 and Casp3) for axon degeneration, we 
predicted that XIAP-deficient neurons may be more vulnerable to caspase-mediated 
degeneration during local deprivation. Indeed, XIAP-deficient neurons degenerated their 
axonsearlier than wild type neurons (Fig. 6a; Supplemental Fig. S3b). Also, significantly 
more Casp3 activation was observed in the cell bodies of locally deprived XIAP-deficient 
neurons compared to wild type neurons (Fig. 6b). These results show that caspase activation 
during axon-selective degeneration is spatially restricted by the activities of the proteasome 
and XIAP.
Mature neurons inhibit apoptosis but permit axon pruning
Our results thus far show that the axon degeneration and apoptosis pathways are distinct but 
share several key components. One question this raises is whether neurons can shut off 
apoptosis while maintaining the ability to undergo axon-selective degeneration. Mature 
neurons provide an excellent model to examine this point because neurons are known to 
restrict the apoptotic pathway with maturation, in part by turning off the expression of 
Apaf-126. Specifically, we and others have shown that global NGF deprivation induces 
apoptosis in young (5 DIV) but not mature (28 DIV) neurons (Fig. 7a)4-7.
To examine whether mature neurons remain permissive for axon-selective degeneration 
despite shutting down their apoptosis pathway, we subjected young and mature neurons to 
local NGF deprivation. Our results show that mature neurons are fully capable of activating 
Casp6 and undergoing axon-selective degeneration as removal of NGF from just the axons 
triggered axon degeneration (Figs. 7b-d). These results are particularly striking since 
removal of NGF from the entire mature neuron (soma and axons) induces neither apoptosis 
nor axon degeneration (Fig. 7a). Thus, the ability of mature neurons to be permissive or 
resistant to axon degeneration depends not only on whether NGF is deprived from the axons, 
but also whether it is present or absent in the soma.
Taken together, our results have identified key differences in the axon degeneration pathway 
depending on whether the context is apoptosis or axon-selective pruning (Fig. 8).
Discussion
Neurons have the unique capability to activate pathways that cause degeneration of either 
the entire cell or only the axons33. The picture that is emerging is that neurons engage 
multiple pathways for triggering axon degeneration that is stimuli-specific. Our results now 
show that even in the context of one stimulus (e.g. NGF deprivation), the spatial origin of 
the stimuli is a key determining factor for activating a specific axon degeneration pathway. 
We find Casp6 to be activated during axon degeneration but selectively in the context of 
NGF deprivation. Indeed, axon degeneration after axotomy, termed Wallerian 
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degeneration34, and axon degeneration induced by other insults such as microtubule 
destabilization are likely mediated by an alternate, Casp6-independent mechanism17,20. The 
observation that neurons activate a specific pathway for axon degeneration that responds 
selectively to NGF deprivation is consistent with the relevance of NGF as a physiological 
factor that regulates sympathetic neuron innervations35 Importantly, we find that even in the 
context of NGF deprivation, Casp6 is essential for axon degeneration only during axon-
specific but not whole cell breakdown. Thus, axon degeneration appears to be critically 
dependent on Casp6 when the insult is physiologically relevant and spatially localized to 
axons.
Our results also make the critical distinction between axon degeneration that occurs during 
apoptosis versus axon-selective pruning. While we and others show that Bax, Casp9, and 
Casp3 are required for axon degeneration13,16,17,19,20, we report the novel finding that 
Apaf-1 is not required for this process. These results were unexpected because the major 
known mechanism for activating Casp9 is via Apaf-1. Incidences of Apaf-1-independent 
Casp9 activation have been reported in non-neuronal models, yet the mechanism remains 
unknown36-38. Our results showing that mature neurons, which lack Apaf-126, were fully 
capable of axon degeneration further supports the model of axon-selective pruning as an 
Apaf-1-independent process. Triggering the complete apoptotic pathway in axons can be 
especially dangerous for neurons, which are post-mitotic cells that must survive long-term. 
Thus, neurons may utilize a non-apoptosome mechanism of activating Casp9 during axon 
pruning to tightly restrict the direct activation of Casp3, therefore avoiding the risk of a 
lethal and widespread apoptotic caspase cascade.
Increasing evidence indicates that neurons utilize Bax, Casp9, and Casp3 for synaptic 
plasticity39. We predict that caspase activation under these non-apoptotic conditions may 
also occur by a pathway that is Apaf-1-independent. Also, while we find cytc to be released 
from the mitochondria in degenerating axons, determining whether it is required for Apaf-1-
independent Casp9 activation needs further investigation. Experiments that knock-down 
cytc are problematic due to the essential function of cytc in mitochondrial respiration. 
However, one potential alternative approach would be to introduce neutralizing antibodies to 
cytc into axons and assess whether axonal degeneration is prevented.
The exact non-apoptosome mechanism by which Casp9 activates the downstream caspases, 
Casp6 and Casp3, remains unclear. A recent study found Casp3 deficiency to block Casp6 
activation, placing Casp6 downstream of Casp3 in this pathway20. While we found Casp6 
activation to be reduced in Casp3-deficient axons during local deprivation, it was 
nevertheless detectable (Fig. 3a). Importantly, this reduced level of Casp6 activation was 
incapable of inducing axon degeneration as axonal integrity was maintained in the locally-
deprived Casp3-deficient neurons. Thus, while Casp3 appears to be needed for the full 
activation of Casp6 during axon pruning, the exact mechanism of this caspase activation 
appears more complex than a linear pathway.
Our results also identify the proteasome and XIAP as two mechanisms by which neurons 
limit caspase activity during axon-selective degeneration. Casp6 is a known target of the 
proteasome31,32 and endogenous XIAP is a potent inhibitor of caspases in neurons12. The 
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protective function of XIAP in the cell body during axon-specific degeneration is similar to 
the mechanism in Drosophila where DIAP (the insect homolog of XIAP) regulates caspase 
activity during developmental dendritic pruning40,41. Our results indicate that neurons have 
evolved multiple mechanisms for restricting axonal caspase activity in order to remodel 
axons without risking long-term survival.
Extensive neuronal apoptosis and axon pruning are both required to establish specific 
neuronal circuitry during development3,8. However, whereas the apoptotic pathway becomes 
highly restricted once neurons are integrated into the nervous system to enable neurons to 
survive for the lifetime of the organism4-7, the selective pruning of axons is continually 
required to permit plasticity in the adult nervous system8-10. Indeed, we find mature neurons 
to fully restrict apoptosis yet remain capable of undergoing axon-specific degeneration. 
Aberrant activation of axon pruning mechanisms in the mature nervous system could 
contribute to pathological axon degeneration in neurodegenerative disease. While inhibiting 
caspases could be a potential therapy in these situations, one concern is that chronic 
administration of caspase inhibitors may also inhibit physiological pruning and synaptic 
plasticity.
Together, our results reveal that neuronsare exquisitely capable of discerning the spatial 
location of NGF signal loss and activating an appropriate response. Neurons appear to 
utilize essentially the same components for whole cell and axon-selective degeneration yet 
have evolved distinct mechanisms to allow precise spatial and temporal control over the 
activation of these pathways.
Materials and Methods
Mice
All animal handling and protocols were carried out in accordance with established practices 
as described in the National Institutes of Health Guide for Care and Use of Laboratory 
Animals and as approved by the Animal Care and Use Committee of the University of North 
Carolina (UNC). Casp6-deficient mice were obtained from Jackson Labs. Mice deficient for 
Casp9, Apaf-1, or Casp3 were dissected at E16.5 due to the embryonic lethality often 
associated with these gene deficiencies at later ages. All knockout mice were on a C57BL/6 
background, and wild type littermates served as controls for all experiments.
Primary sympathetic neuronal cultures
Primary sympathetic neurons were cultured as previously described12. Briefly, sympathetic 
neurons were dissected from the superior cervical ganglia (SCG) of postnatal day (P) 0-1 
CD1 mice. Cells were plated on collagen-coated dishes at a density of 10,000 cells per well 
or in microfluidic chambers (see section below) and maintained for 5 days in vitro (DIV) in 
NGF-containing medium (AM50). For NGF deprivation, cultures were rinsed three times 
with medium lacking NGF (AM0) and then maintained in NGF-deficient media containing a 
neutralizing antibody to NGF. Some neuronal cultures were treated with various compounds 
in the presence of NGF: 20 μM etoposide; 2.5 μM tunicamycin; 1 μM vinblastine. All 
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reagents were obtained from Sigma unless otherwise indicated. All experiments were 
performed in triplicate.
Fabrication and use of microfluidic devices
Standard photolithography was used to fabricate channel array devices for axon growth. 
Negative photoresist (KMPR 1010, MicroChem Corp., Newton, MA) was used to pattern 
arrays of 10-μm-wide, 3-um-deep grooves spaced 40 μm apart onto a standard silicon wafer 
(Silicon Quest International). The bare silicon around the pattern was etched approximately 
3-μm deep using deep reactive ion etching (Alcatel AMS 100 Deep Reactive Ion Etcher) 
with a low-roughness Bosch process. The photoresist was then stripped using 2800 W 
oxygen plasma. The features for the large side compartments (750-μm long, 100-μm-deep, 
1.0-mm-wide on each side) at either end of the central grooves were fabricated onto the 
wafer using negative photoresist (SU8-100, Micro Chem Corp.) and standard 
photolithography using the manufacturer's recommended procedure. Sylgard 184 (Dow 
Corning) was prepared according to the manufacturer's recommended procedure and poured 
into the mold form. After curing at 65°C overnight, individual PDMS chambers were cut 
out, sterilized in 70% EtOH, and placed upon glass coverslips coated with 40 μg/ml poly-D-
lysine (BD Biosciences) and 0.1 μg/mL mouse laminin (Invitrogen).
Culture and treatment of primary neurons
Neurons were plated in microfluidic chambers as described previously24 and maintained in 
AM50 until 5 DIV (or 28 DIV for mature experiments). To achieve global deprivation of 
NGF, both compartments were carefully rinsed three times with AM0 and then maintained 
in AM0 containing NGF-neutralizing antibodies. For local deprivation only the axon 
compartment was rinsed and deprived of NGF whereas the soma compartment was 
maintained in AM50. Chambers containing AM50 in both compartments served as controls. 
A 30 μL volume differential was established between the two compartments at the start of 
treatment and reset every 12-20 hours to maintain fluidic isolation24. Where indicated, 25 
μM zIETD-FMK (Casp8-specific inhibitor, SM Biochemicals) or 25 μM QVD (pan-caspase 
inhibitor, SM Biochemicals) was added at time of treatment. Also, 10 μM Bortezomib was 
added 8-10 hours intotreatment to preclude any toxic effects resulting from longer 
proteasome inhibition.
Quantification
The length of intact axons was measured both before and after treatment. The left edge of 
the chamber's microgrooves (where axons first enter the axon compartment) served as the 
starting point of measurement. Distinct markers were imprinted on the microgrooves during 
the chamber design and fabrication process to allow identification of the same axons and 
chamber regions over time. It is important to note that fragmented axons do not remain 
adhered to the glass cover slip; very slow media flow within the chamber compartment, 
coupled with the absence of a ‘sticky’ matrix such as collagen or methylcellulose, removes 
away the degenerated axon pieces. The microfluidic chamber system permits very clear 
detection of maintained, adherent, and intact axons versus degenerating and non-adherent 
axons (see phase time-course images in Fig. 3d and Fig. 7b). Therefore, we compared the 
length of intact axons both before and after treatment to determine the percentage of each 
Cusack et al. Page 8













measured axon that was maintained and, inversely, the percentage of each measured axon 
that was lost as a result of treatment-induced degeneration.
Immunofluorescence
Immunofluorescence staining was carried out as previously described12. Briefly, cultures 
were gently rinsed in phosphate-buffered saline and fixed in fresh 4% para formaldehyde at 
room temperature for twenty minutes. Cultures were rinsed three times with Tris-buffered 
saline (TBS) and exposed to blocking solution (TBS containing 5% donkey serum and 0.3% 
Triton X-100) for one hour at room temperature. Following blocking, cells were treated with 
primary and secondary antibodies using standard methods and nuclei were labeled with the 
nuclear dye bisbenzimide (Hoechst 33258 at 1 μg/ml, Invitrogen). The same steps were 
carried out in microfluidic chambers by gradually adding solutions to the reservoirs to 
ensure properflow into the soma and axon compartments. For experiments involving 
knockout neurons, cells were fixed when neurons from wild type littermates showed 
extensive axon degeneration following treatment. The following primary antibodies were 
used for immunostaining: cleaved Caspase-6 (Santa Cruz, 1:200), cleaved Caspase-3 (Cell 
Signaling, 1:400), cleaved Caspase-9 (Cell Signaling, 1:400), cytochrome c (Molecular 
Probes, 1:400), Tom20 (Santa Cruz, 1:400), and tubulin (1:400). Tyramide Signal 
Amplification (TSA; Molecular Probes) was used according to manufacturer's instructions 
to visualize cleaved Casp3 in axons and cleaved Casp9.
Image acquisition and processing
Images were acquired by an ORCA-ER digital B/W CCD camera (Hamamatsu) mounted on 
a DMIRE2 inverted fluorescence microscope (Leica) using Metamorph version 7.6 software 
(Molecular Devices).
Statistical Analysis
All p values were calculated using an unpaired t-test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Casp6 activation in axons is selective to NGF deprivation
(a) Wild type (WT) sympathetic neurons (5 DIV) were treated with the following conditions 
to induce axon degeneration, respectively: NGF deprivation (-NGF), 20 μM etoposide (DNA 
Damage), 2.5 μM tunicamycin (ER Stress), and 1 μM vinblastine (to induce microtubule 
destabilization). NGF-maintained neurons served as controls. Neurons were fixed and 
immunostained for tubulin upon axon beading and fragmentation. (b) Neurons were treated 
as described in (a) and immunostained for cleaved Casp3 and cleaved Casp6. Nuclei were 
labeled with Hoechst. Scale bar, 20 μm.
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Figure 2. Casp6 is required for axon degeneration during axon pruning but not apoptosis
(a) WT and Casp6-deficient (Casp6 KO) neurons(5 DIV) were NGF-deprived for 24 hours. 
WT neurons maintained in NGF served as a control. Scale bar, 10 μm. (b) Microfluidic 
chamber model of global deprivation, which induces soma and axon degeneration, and local 
deprivation, which results in axon-selective degeneration. (c) WT and Casp6-deficient 
neurons were NGF-maintained, globally deprived, or locally deprived. Neurons were 
immunostained for tubulin and nuclei were labeled with Hoechst. Scale bar, 50 μm. (d) 
Quantification of axon degeneration for conditions shown in (c). Data represent the mean ± 
s.e.m. (n=3). P values were calculated using an unpaired t-test.
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Figure 3. Axon-selective degeneration is Apaf-1-independent but requires Casp9 and Casp3
(a) Sympathetic neurons (5 DIV) from mice deficient for Bax, Apaf-1, Casp9, Casp6, and 
Casp3 were locally deprived in microfluidic chambers. NGF-maintained and locally 
deprived WT littermate neurons served as controls. Neurons were immunostained for 
tubulin and cleaved Casp6. (b) WT neurons were locally deprived for 24 hours and probed 
for cleaved Casp3. NGF-maintained neurons served as controls. (c) Quantification of axon 
degeneration for conditions shown in (a). (d) Quantification of maintained axon length over 
time during local deprivation for all conditions shown in (a). All data represent the mean ± 
s.e.m. (n=3). (e) Phase images of the same axons over a 36-hour timecourse of local 
deprivation demonstrate similar degeneration kinetics between WT and Apaf-1-deficient 
axons. All p values were calculated using an unpaired t-test. All Scale bars, 50 μm.
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Figure 4. Local deprivation triggers cytc release in axons
Neurons (5 DIV) were NGF-maintained, globally deprived, or locally deprived in the 
presence of pan-caspase inhibitor (25 μM QVD) for 36 hours and probed for cytc and the 
mitochondrial marker Tom20. Quantification of the colocalization index (ImageJ) for cytc 
and Tom20 is shown below. Data represent the mean ± s.e.m. (n=3). Scale bar, 10 μm. All p 
values were calculated using an unpaired t-test.
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Figure 5. The proteasome restrictscaspase activation to axons during axon-specific degeneration
(a) WT neurons were NGF-maintained or locally deprived in the absence (-) or presence (+) 
of the proteasome inhibitor Bortezomib. Neurons were immunostained for cleaved Casp6 
and tubulin (inset). Scale bar, 50 μm. Quantification of axon degeneration is shown on the 
right. (b) Cell bodies of neurons treated as described in (a) were immunostained for cleaved 
Casp3. Nuclei were labeled with Hoechst. Scale bar, 20 μm. Quantification of cleaved 
Casp3-positive cell bodies is shown on the right. (c) Cell bodies of neurons treated as 
described in (a) were immunostained for cleaved Casp9 and nuclei were labeled with 
Hoechst. Scale bar, 20 μm. Quantification of cleaved Casp9-positive cell bodies is shown on 
the right. (d) WT and Casp3-deficient neurons were locally deprived with (+) and without 
(-) Bortezomib and probed for tubulin. NGF-maintained neurons served as controls. Scale 
bar, 50 μm. Quantification of axon degeneration is shown on the right. All data represent the 
mean ± s.e.m. (n=3). All p values were calculated using an unpaired t-test.
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Figure 6. XIAP protects the soma from caspase activation during axon-specific degeneration
(a)WT or XIAP-deficient neurons were locally deprived and probed for cleaved Casp6. 
Arrows indicate early signs of axonal collapse. Scale bar, 50 μm. Quantification of axon 
degeneration is shown on the right. (b) WT and XIAP-deficient neurons were NGF-
maintained or locally deprived and cell bodies were probed for cleaved Casp3. Nuclei were 
labeled with Hoechst. Scale bar, 20 μm. Quantification of the percentage of cell bodies 
positively labeled for cleaved Casp3 is shown on the right. All data represent the mean ± 
s.e.m. (n=3). All p values were calculated using an unpaired t-test.
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Figure 7. Mature neurons inhibit apoptosis during global deprivation but degenerate axons 
during local deprivation
(a) Young (5 DIV) and mature (28 DIV) sympathetic neurons were either NGF-maintained 
or NGF-deprived for 48 hours. Scale bar, 20 μm. (b) The same axons of young and mature 
neurons were imaged every 24 hours during local deprivation. NGF-maintained neurons at 
both ages served as controls. Scale bar, 50 μm. (c) Quantification of axon degeneration for 
conditions shown in (b). Data represent the mean ± s.e.m. (n=3). (d) Cleaved Casp6 
immunostaining and corresponding phase images (inset) in the axon compartments of 
conditions shown in (b). All p values were calculated using an unpaired t-test.
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Figure 8. Working model of the pathways mediating apoptosis versus axon pruning
Proteins highlighted in yellow have been shown to be required for both apoptosis and axon 
pruning pathways. Our results indicate that Apaf-1 and Caspase-6 (highlighted in blue) are 
two points of divergence. Future experiments will be required to determine what role, if any, 
is played by the mitochondria and cytc release in axon-selective degeneration. In addition, 
how Caspase-9 is able to activate Caspase-6 and Caspase-3 without Apaf-1 remains to be 
determined. While Casp6 and Casp3 are both required for axon pruning, their exact order of 
activation during axon pruning in neurons is still unclear.
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